The regulatory context for compounded GLP-1 in 2026 FDA removed semaglutide from its drug shortage list in early 2025, which changed the primary legal basis that had allowed widespread compounding of semaglutide under shortage-exemption rules
Confusing them is the most common mistake in GH peptide dosing
It is present naturally in every cell of the body, as well as in the blood, the bile and the fluid lining the lungs
Avoid using semaglutide or its combination with vitamins if you have a history of thyroid cancer, pancreatitis, severe gastrointestinal disorders, or multiple endocrine neoplasia type 2 (MEN2)
Orbera & Spatz3 Gastric Balloons: Temporary, non-surgical balloons that take up space in your stomach, reducing appetite and training you to eat less
Semaglutide GLP-1 typically starts to reduce appetite within the first few days to a week of treatment